Modeling patients’ time, travel, and monitoring costs in anticoagulation management: societal savings achievable with the shift from warfarin to direct oral anticoagulants

Modeling patients’ time, travel, and monitoring costs in anticoagulation management: societal savings achievable with the shift from warfarin to direct oral anticoagulants

Abstract Background Anticoagulation therapy is used for atrial fibrillation (AF) patients for reducing the risk of cardioembolic complications such as stroke. The previously recommended anticoagulant, warfarin, has a narrow therapeutic window, and it requires regular laboratory monitoring, unlike di...

Full description

Bibliographic Details
Main Authors: Aapeli Leminen, Mikko Pyykönen, Juho Tynkkynen, Markku Tykkyläinen, Tiina Laatikainen
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Health Services Research
Subjects:
Atrial fibrillation
INR monitoring
DOAC
Real-world data
Network analysis
Accessibility
Online Access:http://link.springer.com/article/10.1186/s12913-019-4711-z

Internet

http://link.springer.com/article/10.1186/s12913-019-4711-z

Similar Items